Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Return on Assets (2016 - 2025)

Sunshine Biopharma (SBFM) has disclosed Return on Assets for 12 consecutive years, with 0.19% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets fell 5.0% year-over-year to 0.19%, compared with a TTM value of 0.19% through Sep 2025, down 5.0%, and an annual FY2024 reading of 0.18%, down 2.0% over the prior year.
  • Return on Assets was 0.19% for Q3 2025 at Sunshine Biopharma, up from 0.21% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.06% in Q3 2022 and bottomed at 6.07% in Q3 2021.
  • Average Return on Assets over 5 years is 1.41%, with a median of 0.21% recorded in 2025.
  • The sharpest move saw Return on Assets tumbled -423bps in 2021, then surged 601bps in 2022.
  • Year by year, Return on Assets stood at 5.29% in 2021, then surged by 86bps to 0.76% in 2022, then skyrocketed by 79bps to 0.16% in 2023, then fell by -3bps to 0.17% in 2024, then dropped by -12bps to 0.19% in 2025.
  • Business Quant data shows Return on Assets for SBFM at 0.19% in Q3 2025, 0.21% in Q2 2025, and 0.17% in Q1 2025.